Prokidney Corp. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -26.75M-55.15M-148.13M-135.45M-163.34M
Depreciation and Depletion 0.61M1.45M2.45M2.96M4.34M
Share-based Compensation 0.73M0.70M74.47M30.85M29.37M
Gains from Sales and Divestitures 1.73M2.27M1.34M
Gains from Investment Securities 0.14M0.07M9.50M14.68M21.45M
Asset Writedowns and Impairment 5.32M
Non-cash Items 0.19M20.75M2.20M
Change in Interest Receivables 1.38M1.07M
Cash from Operations -25.18M-50.30M-77.09M-90.07M-126.35M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.96M1.98M3.04M3.85M5.43M
Change in Working Capital
Change in Accured Expenses 0.68M7.87M0.49M11.64M11.59M
Change in Taxes 0.28M1.76M-0.61M
Investing Activities
Capital Expenditures 5.46M5.19M1.85M34.20M29.51M
Sales of Property, Plant and Equipment 0.00M
Divestments 542.50M
Change in Acquisitions & Divestments 175.82M373.95M
Cash from Investing Activities -5.46M-5.19M-1.74M-329.98M20.41M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 35.00M
Change in Capital Stock
Shares Issued 144.32M
Shares Repurchased 9.50M
Misc.
Cash from Financing Activities 19.99M71.47M548.52M-9.55M144.41M
Change in Cash -10.65M15.98M469.69M-429.60M38.47M
Beginning Cash Balance 35.00M
Free Cash Flow -30.64M-55.49M-78.94M-124.27M-155.86M
Net Cash Flow -10.65M15.98M469.69M-429.60M38.47M